002004.SZ
002004.SZ
CNE000001JJ6
HUAPONT LIFESCIENCES
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 85/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±28.9% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.32x
Defensive
Volatility (5Y p.a.)
28.9% p.a.
5-Year Horizon
Max Drawdown (5Y)
-51.0%
5-Year Horizon
Sharpe Ratio
-0.35
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — 0%
3 Years 28.6% -33.2% -0.17 -2.5%
5 Years 28.9% -51.0% -0.35 -8%
10 Years 29.8% -62.6% -0.33 -7.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -62.6% in the extended horizon.
ende